{"2502.06890": {"publish_time": "2025-02-09", "title": "LLMs for Drug-Drug Interaction Prediction: A Comprehensive Comparison", "paper_summary": "The increasing volume of drug combinations in modern therapeutic regimens\nneeds reliable methods for predicting drug-drug interactions (DDIs). While\nLarge Language Models (LLMs) have revolutionized various domains, their\npotential in pharmaceutical research, particularly in DDI prediction, remains\nlargely unexplored. This study thoroughly investigates LLMs' capabilities in\npredicting DDIs by uniquely processing molecular structures (SMILES), target\norganisms, and gene interaction data as raw text input from the latest DrugBank\ndataset. We evaluated 18 different LLMs, including proprietary models (GPT-4,\nClaude, Gemini) and open-source variants (from 1.5B to 72B parameters), first\nassessing their zero-shot capabilities in DDI prediction. We then fine-tuned\nselected models (GPT-4, Phi-3.5 2.7B, Qwen-2.5 3B, Gemma-2 9B, and Deepseek R1\ndistilled Qwen 1.5B) to optimize their performance. Our comprehensive\nevaluation framework included validation across 13 external DDI datasets,\ncomparing against traditional approaches such as l2-regularized logistic\nregression. Fine-tuned LLMs demonstrated superior performance, with Phi-3.5\n2.7B achieving a sensitivity of 0.978 in DDI prediction, with an accuracy of\n0.919 on balanced datasets (50% positive, 50% negative cases). This result\nrepresents an improvement over both zero-shot predictions and state-of-the-art\nmachine-learning methods used for DDI prediction. Our analysis reveals that\nLLMs can effectively capture complex molecular interaction patterns and cases\nwhere drug pairs target common genes, making them valuable tools for practical\napplications in pharmaceutical research and clinical settings.", "paper_summary_zh": "<paragraph>\u73fe\u4ee3\u6cbb\u7642\u65b9\u6848\u4e2d\u85e5\u7269\u7d44\u5408\u7684\u6578\u91cf\u8d8a\u4f86\u8d8a\u591a\uff0c\u9700\u8981\u53ef\u9760\u7684\u65b9\u6cd5\u4f86\u9810\u6e2c\u85e5\u7269\u9593\u4ea4\u4e92\u4f5c\u7528 (DDI)\u3002\u5118\u7ba1\u5927\u578b\u8a9e\u8a00\u6a21\u578b (LLM) \u5df2\u5728\u5404\u500b\u9818\u57df\u6380\u8d77\u9769\u547d\uff0c\u5b83\u5011\u5728\u85e5\u7269\u7814\u7a76\u4e2d\u7684\u6f5b\u529b\uff0c\u7279\u5225\u662f\u5728 DDI \u9810\u6e2c\u4e2d\u7684\u6f5b\u529b\uff0c\u4ecd\u672a\u5f97\u5230\u5145\u5206\u63a2\u7d22\u3002\u672c\u7814\u7a76\u901a\u904e\u7368\u7279\u5730\u8655\u7406\u5206\u5b50\u7d50\u69cb (SMILES)\u3001\u76ee\u6a19\u751f\u7269\u548c\u57fa\u56e0\u4ea4\u4e92\u8cc7\u6599\u4f5c\u70ba\u4f86\u81ea\u6700\u65b0 DrugBank \u8cc7\u6599\u96c6\u7684\u539f\u59cb\u6587\u5b57\u8f38\u5165\uff0c\u5fb9\u5e95\u8abf\u67e5\u4e86 LLM \u5728\u9810\u6e2c DDI \u4e2d\u7684\u80fd\u529b\u3002\u6211\u5011\u8a55\u4f30\u4e86 18 \u7a2e\u4e0d\u540c\u7684 LLM\uff0c\u5305\u62ec\u5c08\u6709\u6a21\u578b\uff08GPT-4\u3001Claude\u3001Gemini\uff09\u548c\u958b\u6e90\u8b8a\u9ad4\uff08\u5f9e 1.5B \u5230 72B \u53c3\u6578\uff09\uff0c\u9996\u5148\u8a55\u4f30\u5b83\u5011\u5728 DDI \u9810\u6e2c\u4e2d\u7684\u96f6\u6b21\u5b78\u7fd2\u80fd\u529b\u3002\u7136\u5f8c\uff0c\u6211\u5011\u5fae\u8abf\u9078\u5b9a\u7684\u6a21\u578b\uff08GPT-4\u3001Phi-3.5 2.7B\u3001Qwen-2.5 3B\u3001Gemma-2 9B \u548c Deepseek R1 \u84b8\u993e Qwen 1.5B\uff09\u4ee5\u6700\u4f73\u5316\u5176\u6548\u80fd\u3002\u6211\u5011\u7684\u5168\u9762\u8a55\u4f30\u6846\u67b6\u5305\u62ec\u8de8 13 \u500b\u5916\u90e8 DDI \u8cc7\u6599\u96c6\u9032\u884c\u9a57\u8b49\uff0c\u4e26\u8207\u50b3\u7d71\u65b9\u6cd5\uff08\u4f8b\u5982 l2 \u6b63\u5247\u5316\u908f\u8f2f\u8ff4\u6b78\uff09\u9032\u884c\u6bd4\u8f03\u3002\u5fae\u8abf\u5f8c\u7684 LLM \u8868\u73fe\u51fa\u512a\u7570\u7684\u6548\u80fd\uff0c\u5176\u4e2d Phi-3.5 2.7B \u5728 DDI \u9810\u6e2c\u4e2d\u9054\u5230 0.978 \u7684\u9748\u654f\u5ea6\uff0c\u5728\u5e73\u8861\u8cc7\u6599\u96c6\uff0850% \u6b63\u4f8b\uff0c50% \u53cd\u4f8b\uff09\u4e0a\u7684\u6e96\u78ba\u5ea6\u70ba 0.919\u3002\u6b64\u7d50\u679c\u512a\u65bc\u96f6\u6b21\u5b78\u7fd2\u9810\u6e2c\u548c\u7528\u65bc DDI \u9810\u6e2c\u7684\u6700\u65b0\u6a5f\u5668\u5b78\u7fd2\u65b9\u6cd5\u3002\u6211\u5011\u7684\u5206\u6790\u8868\u660e\uff0cLLM \u53ef\u4ee5\u6709\u6548\u6355\u6349\u8907\u96dc\u7684\u5206\u5b50\u4ea4\u4e92\u6a21\u5f0f\u548c\u85e5\u7269\u5c0d\u9776\u5411\u5171\u540c\u57fa\u56e0\u7684\u60c5\u6cc1\uff0c\u4f7f\u5176\u6210\u70ba\u85e5\u7269\u7814\u7a76\u548c\u81e8\u5e8a\u74b0\u5883\u4e2d\u5be6\u7528\u61c9\u7528\u7684\u5bf6\u8cb4\u5de5\u5177\u3002</paragraph>", "author": "Gabriele De Vito et.al.", "authors": "Gabriele De Vito, Filomena Ferrucci, Athanasios Angelakis", "id": "2502.06890v1", "paper_url": "http://arxiv.org/abs/2502.06890v1", "repo": "null"}}